Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Iveco gets India entry while Tata gains Latin American access
TaMo plans to tap into premium customer segments and cohorts of Iveco which complements its current positioning
Trump on Wednesday called India's tariffs on US exports among the highest in the world, with the most strenuous non-monetary trade barriers of any country, in a post on Truth Social
Auto volumes rise 17 per cent, SUV market share improves 570 bps to 27.3 per cent, while farm and services also report healthy margins and profits in Q1FY26
Strong demand for electric SUVs boosts Mahindra's EV business to Rs 111 crore EBITDA in Q1FY26; company awaits PLI certificate and ramps up production gradually
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed
US biotech funding slowdown hits Piramal's CDMO business as company expands sterile injectables facility and maintains long-term growth targets
Chief operating officer of consumer goods conglomerate will succeed Jon Moeller
Firm proceeds with AGM despite objections from Kapur's mother
The NPPA will ensure drug companies do not exceed the 10% annual price increase limit on non-essential medicines
Under the FTA, tariffs on automotive imports will come down by 50 per cent over 10 years (out of quota)
The UK-India Free Trade Agreement is expected to boost trade in pharmaceuticals and medical devices, though industry players remain cautious about the impact of country of origin rules
Fronx drives Maruti Suzuki's record FY25 exports with 69,000 units shipped globally, becoming the fastest SUV to cross 100,000 units in overseas sales
In a major product launch from Renault in five years, the company on Wednesday launched a next-generation Triber priced attractively between ₹6.2 lakh and ₹8.4 lakh
Hospitals have a steady quarter with occupancies rising 100 bps
Many see Tesla's India entry as an attempt to address the capacity glut at its global plants, from where excess inventory might be brought to India
Tesla opens bookings for Model Y in India at up to ₹67.89 lakh due to high import duties, with first deliveries expected later in 2025 from Shanghai plant
Downside risks from rare-earth magnets an overhang for the sector
Bengaluru-based Manipal Hospitals cements top spot with major expansion, aims IPO
IGI Therapeutics, a wholly owned subsidiary of Glenmark, has licensed its cancer and autoimmune drug ISB 2001 to AbbVie for an upfront payment of $700 million